Multi-Omics Analysis of MCM2 as a Promising Biomarker in Pan-Cancer
Minichromosome maintenance 2 (MCM2) is a member of the minichromosomal maintenance family of proteins that mainly regulates DNA replication and the cell cycle and is involved in regulating cancer cell proliferation in various cancers. Previous studies have reported that MCM2 plays a pivotal role in...
Main Authors: | Jing Yuan, Hua Lan, Dongqing Huang, Xiaohui Guo, Chu Liu, Shuping Liu, Peng Zhang, Yan Cheng, Songshu Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.852135/full |
Similar Items
-
Multi-omics pan-cancer analyses identify MCM4 as a promising prognostic and diagnostic biomarker
by: Yanxing Li, et al.
Published: (2024-03-01) -
Identification of Potential Biomarkers and Small Molecule Drugs for Cutaneous Melanoma Using Integrated Bioinformatic Analysis
by: Yong Liu, et al.
Published: (2022-03-01) -
High Expression of TIMELESS Predicts Poor Prognosis: A Potential Therapeutic Target for Skin Cutaneous Melanoma
by: Shixin Zhao, et al.
Published: (2022-05-01) -
Identification of Potential Prognostic Biomarkers Associated With Cancerometastasis in Skin Cutaneous Melanoma
by: Yang Li, et al.
Published: (2021-07-01) -
MCM10 is a Prognostic Biomarker and Correlated With Immune Checkpoints in Ovarian Cancer
by: Zhenzhen Wu, et al.
Published: (2022-05-01)